QualityStocksNewsBreaks Archives - Page 173 of 1537

ThursdayApr 17, 2025 12:05 pm

QualityStocksNewsBreaks – ROTH Conference Marks a Quarter-Century of Community in Dana Point

The 37th Annual ROTH Conference drew thousands of participants from around the globe to Dana Point, California, the host location of the event for the past 25 years. In addition to a successful gathering of institutional investors, company executives, and industry visionaries, this year’s conference marked a milestone in Roth Capital Partners, LLC’s (“ROTH”) enduring commitment to the local community that has helped shape the event’s identity over the last quarter-century. “The Dana Point community has been an incredible partner to us over the last 25 years,” said ROTH CFO Gordon Roth. “We are honored and deeply grateful for the…

ThursdayApr 17, 2025 9:35 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Reports Record Attendance and Revenue Boost at Juve Stabia Derby

Brera Holdings (NASDAQ: BREA) announced that its Serie B club, S.S. Juve Stabia, achieved its highest home attendance of the season with 7,000 fans at the April 5 derby against Salernitana—just shy of a sellout at Stadio Romeo Menti. The turnout marks a key step in the club’s commercial strategy to boost matchday revenue and long-term fan engagement. Juve Stabia ranks 5th in Serie B and has seen its squad value surge 36.9% to €16.13 million, as Brera advances its multi-club ownership model through both on-field success and off-field monetization. To view the full press release, visit https://ibn.fm/29ELZ About Brera Holdings…

ThursdayApr 17, 2025 9:25 am

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Clearance to Begin Trials for CLD-201 in Solid Tumors

Calidi Biotherapeutics (NYSE American: CLDI) announced FDA clearance of its Investigational New Drug application for CLD-201, an allogeneic stem cell-based virotherapy targeting solid tumors including breast cancer, head and neck cancer, and soft tissue sarcoma. Backed by preclinical data showing immune system evasion and potent tumor-killing ability, CLD-201 is now cleared to enter clinical development. The therapy combines adipose-derived stem cells with oncolytic vaccinia virus, representing a novel immunotherapeutic approach for hard-to-treat cancers. To view the full press release, visit: https://ibn.fm/362xV About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s…

WednesdayApr 16, 2025 12:20 pm

QualityStocksNewsBreaks – ProPhase Labs Inc. (NASDAQ: PRPH) Closes $23.6M Sale to Focus on Core Businesses

ProPhase (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics company, earlier this year announced the closing of the sale of its wholly owned subsidiaries, Pharmaloz Manufacturing Inc. and Pharmaloz Real Estate Holdings Inc. (collectively “Pharmaloz” or “PMI”), to a private equity group based in Houston, Texas. The transaction’s aggregate deal was valued at approximately $23.6 million, which immediately bolstered ProPhase’s balance sheet and liquidity by eliminating over $20 million in debt, payables, and other contingent liabilities. Overall, the transaction better positioned ProPhase to focus on its promising and high-value core businesses. To view the full press release, visit https://ibn.fm/ardt7 About…

TuesdayApr 15, 2025 12:15 pm

QualityStocksNewsBreaks – EZCORP Inc. (NASDAQ: EZPW) Secures $300M in Private Offering

EZCORP (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, recently closed a private offering of $300 million of 7.375% senior notes due 2032. The company expects to use approximately $103.4 million of the net proceeds to repay its outstanding 2.375% convertible senior notes due 2025 at maturity. EZCORP intends to use any excess proceeds for general corporate purposes. Roth Capital Partners acted as co-manager for the transaction. For more information, visit https://ibn.fm/yVmWD About EZCORP Formed in 1989, EZCORP has grown into a leading provider of pawn transactions in the United States and Latin…

TuesdayApr 15, 2025 9:35 am

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Expands Tour Presence with Strategic Representative Appointments

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf brand, has appointed Andy Harris and Jeff Opheim as new Tour representatives for the PGA TOUR, PGA TOUR Champions, and Korn Ferry Tour. Founder and CTO Aki Yorihiro will also serve as a Tour representative for the LPGA and PGA TOUR Champions, reinforcing Newton Golf’s footprint across top-tier golf circuits. With a growing ambassador portfolio and over 30 professionals using its Newton Motion shafts and Gravity putters, the company is focused on leveraging swing data and performance feedback to drive innovation and brand growth. To view the full press release, visit https://ibn.fm/Wiur2…

TuesdayApr 15, 2025 8:30 am

QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Secures Military Contract Extension for Iridium PTT Services

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced that its subsidiary, Global Telesat Communications Ltd., received a one-year contract extension from an African military customer for wireless connectivity services. The renewal builds on a 2024 deal for Iridium Push-To-Talk (PTT) hardware and airtime services, which marked the largest such contract in company history. The extension includes options for additional hardware and annual service renewals and is not impacted by recent U.S. tariffs. The Iridium Extreme PTT devices are favored for their secure, global communication capabilities in high-demand government, military and enterprise applications. To view the full press release, visit:…

MondayApr 14, 2025 1:50 pm

QualityStocksNewsBreaks – Immunic Inc. (NASDAQ: IMUX) Closes $5.1M Registered Direct

Immunic (NASDAQ: IMUX),a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, has closed its previously announced registered direct offering of 5,666,667 shares of its common stock, each at a price of $0.90, led by Aberdeen Investments. Immunic secured approximately $5.1 million in gross proceeds, from which it intends to use the net to fund its clinical trials and operations and for other general corporate purposes. Titan Partners Group, a division of American Capital Partners, acted as the sole placement agent for the offering. To view the full press release, visit…

MondayApr 14, 2025 1:25 pm

QualityStocksNewsBreaks – Gaia Inc. (NASDAQ: GAIA) Secures $7.2M in Underwritten Public Offering

Gaia (NASDAQ: GAIA), a conscious media and community company, recently announced the closing of its underwritten public offering of 1,600,000 shares of its Class A common stock at a price to the public of $5.00 per share. The company secured approximately $7.2 million in net proceeds from the offering, which it intends to use primarily for, but not limited to, enhancements of its artificial intelligence (“AI”) capabilities, the development of the Gaia Community project, and for general corporate purposes. Roth Capital Partners acted as joint book-running manager for the offering. For more information, visit https://ibn.fm/gO9Y4 About Gaia Inc. Gaia is…

MondayApr 14, 2025 1:15 pm

QualityStocksNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Faces FTC Antitrust Trial Over Social Media Dominance

Meta Platforms (NASDAQ: META) began its high-stakes antitrust battle with the Federal Trade Commission (FTC) as the trial opened in federal court Monday. The FTC accuses Meta of illegally maintaining a social media monopoly through acquisitions of Instagram and WhatsApp, which the agency argues were strategic moves to suppress competition. The outcome could reshape how tech giants operate and acquire competitors, with potential ripple effects across the digital advertising landscape. Meta contends the acquisitions were legal and enhanced consumer choice, setting up a closely watched legal showdown. Meta shares are trading at $488.47, down 0.6% as the trial’s implications weigh…

Site Search

Company Search

Category: QualityStocksNewsBreaks